Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization
Open Access
- 21 February 2006
- journal article
- Published by Wiley in American Journal of Hematology
- Vol. 81 (3), 218-219
- https://doi.org/10.1002/ajh.20506
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Experiences with recombinant human factor VIIa in patients with thrombocytopeniaSeminars in Hematology, 2004
- Use of recombinant factor VIIa in life-threatening bleeding following autologous peripheral blood stem cell transplantation complicated by platelet refractorinessBone Marrow Transplantation, 2003
- Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhageAmerican Journal of Hematology, 2002
- High‐dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia‐like conditions in a cell‐based model systemBritish Journal of Haematology, 2001
- Clinical Experience with Recombinant Factor VIla in Patients with ThrombocytopeniaPathophysiology of Haemostasis and Thrombosis, 1996